2021
DOI: 10.1080/09674845.2021.1903683
|View full text |Cite
|
Sign up to set email alerts
|

Infectious Mononucleosis: diagnosis and clinical interpretation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 78 publications
0
26
0
Order By: Relevance
“…Epstein–Barr virus (EBV) is a common pathogen that can cause a variety of systemic infections. Among them is infectious mononucleosis (IM), otherwise known as glandular fever, and presents symptomatically with fever, pharyngitis, neck lymphadenopathy, fatiguability, and splenomegaly [ 1 ]. A less clinically ubiquitous sign is bilateral periorbital oedema or ‘Hoagland sign’ [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Epstein–Barr virus (EBV) is a common pathogen that can cause a variety of systemic infections. Among them is infectious mononucleosis (IM), otherwise known as glandular fever, and presents symptomatically with fever, pharyngitis, neck lymphadenopathy, fatiguability, and splenomegaly [ 1 ]. A less clinically ubiquitous sign is bilateral periorbital oedema or ‘Hoagland sign’ [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…EBV infection is common, with more than 95% of all adults worldwide estimated to be seropositive for EBV. 4 EBV is typically transmitted person-to-person via exposure to infected saliva through kissing, sharing of food or drink, coughing, and, less commonly, through sexual transmission. Rarely, EBV can be transmitted by blood transfusion, solid organ transplant, or hematopoietic stem cell transplant.…”
Section: Discussionmentioning
confidence: 99%
“…Cell culture 5×10 5 of PBMCs from 16 randomly selected IM patients were stimulated with gefitinib (R&D Systems, Minneapolis, MN, USA; final concentration: 1 µg/mL), which inhibits tyrosine kinase activity of EGFR through binding to the adenosine triphosphate-binding domain [25], for 72 h. 5×10 5 of PBMCs from 13 randomly selected IM patients were stimulated with AREG (the ligand for EGFR) (R&D Systems, Minneapolis, MN, USA; final concentration: 100 ng/mL) [21] in the presence or absence of anti-HIF-1α (R&D Systems, Minneapolis, MN, USA; Clone #241809; final concentration: 5 µg/mL) for 72 h. Gefitinib is an EGFR inhibitor that interrupts signaling by EGFR in target cells. AREG is a member of the EGF family.…”
Section: Plasma and Peripheral Blood Mononuclear Cells Isolationmentioning
confidence: 99%
“…Treatment of IM patients includes anti-EBV and supportive therapy. However, no antiviral agent has been confirmed for treatment of EBV infection and clinical efficacy is limited [ 5 ]. Importantly, the pathogenesis of IM is not fully understood, which limits the development of antiviral strategies for EBV-induced IM patients.…”
Section: Introductionmentioning
confidence: 99%